FCPA/Anti-Corruption Compliance in Life Sciences and Pharmaceutical Industry: A 2017 Update

Broadcast Date: Tuesday, March 14, 2017 from 12:00 pm to 2:00 pm (ET)
Glenn Pomerantz, CPA, CFE
Mary Bennett
Jeffrey Antoon
Gary Fair
Jane H. Yoon


About BDO Consulting

About BDO’s Global Forensics Practice

The Global Forensics practice at BDO provides insight and forensic resources for high-stakes matters involving fraud and corruption, accounting irregularities, and compliance issues. Around the world, and across all major industries, we are recognized for the depth of our understanding, the breadth of our resources, and the credibility of our analyses. Learn more at bdo.global 

Website: https://www.bdo.com/


Empowering You to Safeguard Your Organization from Ethics & Compliance Risk

We help more than 12,500 organizations worldwide contain compliance risks amidst a never-ending stream of rapidly evolving internal and external threats. Our full suite of proven software, services and expertise helps you ensure that your E&C program is proactive, thorough and effective.

Our mission is to help organizations protect and defend their people, reputation and bottom line—and help them maintain a resilient, ethical organizational culture that helps repel risk.

Website: http://www.navexglobal.com/

About Johnson & Johnson

Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace innovation—bringing ideas, products and services to life to advance the health and well-being of people around the world. We believe in collaboration, and that has led to breakthrough after breakthrough, from medical miracles that have changed lives, to the simple consumer products that make every day a little better. Our over 125,000 employees in 60 countries are united in a common mission: To help people everywhere live longer, healthier, happier lives.

Johnson & Johnson, through its family of companies, is engaged in the research and development, manufacture and sale of a broad range of products in the health care field in virtually all countries of the world. Johnson & Johnson's primary interest, both historically and currently, has been in products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887.

Johnson & Johnson operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care, oral care skin care, and wound care products.  This segment also provides over-the-counter medicines, including acetaminophen products, cold, flu, and allergy products, and ibuprofen products. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. 

About Paul Hastings

Paul Hastings provides innovative compliance and legal solutions to many of the world's top pharmaceutical and life sciences companies, large and small, in markets across Asia, Europe, Latin America, and the United States. We offer a complete portfolio of services to support our clients' complex, often mission-critical needs--from structuring transactions, to protecting critical intellectual property, to resolving complicated U.S. healthcare and global anti-corruption enforcement matters, to providing the savvy compliance and legal counsel that keeps business moving forward.

Paul Hastings has grown steadily and strategically along with our clients across global markets in the critical pharmaceutical and life sciences sector. We have a significant and strategic presence across Europe, and were one of the first U.S. law firms to establish a presence in Asia, where we continue to be a leader in the region, and have significantly expanded our support for clients in Brazil, out of our new São Paulo office, and other emerging markets of Latin America.